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ABSTRACT
Tetrabenazine (TBZ), a vesicular monoamine transporter type 2 (VMAT-2) inhibitor,
depletes dopamine and induces motivational deficits and other depressive symptoms in
humans. Methylphenidate (MPH) is a dopamine transport blocker that is used to enhance
motivational function. Previous studies have shown that in male rats, TBZ induces a shift
in effort-related choice such that a low-effort bias is induced. In male rats this occurs at a
dose range of 0.75-1.0 mg/kg TBZ, and this effect is reversible with co-administration of
MPH. Recent studies have shown that females need a higher dose of TBZ (2.0 mg/kg) to
show the low-effort bias. The present study tested the ability of MPH to reverse the
effects of 2.0 mg/kg TBZ in female rats using an effort-based choice task. Food-restricted
female rats (n=8) were trained on a fixed-ratio (FR) 5/chow feeding choice task in which
they can choose between the high effort/high reward option (FR5 lever pressing for
preferred food, which was Bioserve pellets) or the low effort/low reward option
(consuming the concurrently available but less preferred lab chow). After initial training,
rats were tested in a repeated measure design in which they received combined
treatments of either a vehicle control solution, 2.0 mg/kg TBZ, or TBZ plus various doses
of MPH ranging (0.5 - 4.0 mg/kg MPH) prior to testing. TBZ significantly reduced lever
pressing and increased chow intake, and this effect was reversed by 2.0 mg/kg MPH. This
study shows that MPH can treat motivational deficits induced by TBZ in female rats as
well as male rats.
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INTRODUCTION
MOTIVATION
It is crucial for the survival of any organism to be able to overcome obstacles or
environmental constraints in order to gain access to necessary stimuli (such as food,
water, or appropriate shelter). For example, animals under prey will have heightened
vigilance and physiological mobilization necessary to escape and survive a predator
(Löw et al., 2008) and the phenomenon of motivation is key to responses such as this.
Motivation is the set of processes that allow organisms to regulate internal and external
environments and control the probability, proximity, and availability of stimuli
(Salamone 1992, Salamone et al. 2016) . There are many aspects of motivation, but two
main facets are directional and activational. Directional aspects of motivation refer to
the fact that behavior can be directed towards or away from certain stimuli, whereas
activational aspects of motivation refers to the energetic component and is characterized
by an ability to initiate and maintain rapid or vigorous responses over time (Salamone et
al. 2016, Nunes et al. 2013b). Activational aspects of motivation are clinically important
in humans, as deficits in this type of function span multiple psychiatric disorders. Thus,
studying the neural mechanisms underlying dysfunctions in activational aspects of
motivation is critical for finding relevant treatments.
According to Demyttenaere et al. (2005), fatigue is one of the main depressive symptoms
reported in the psychiatric literature. Fatigue (referred to as central fatigue, rather than
muscle fatigue) is characterized by reduced self-reported energy and impaired
goal-directed activity, and is debilitating to normal human functions and is present in a
wide variety of psychiatric disorders. While major depressive disorder is most
5

commonly associated with a lack of motivation, other psychiatric and neurological
disorders have a high comorbidity with this symptom including schizophrenia,
parkinsonism, bipolar disorder, and multiple sclerosis (Demyttenaere et al. 2005,
Salamone et al. 2016). Given the importance and relevance of motivational problems
among several mental disorders, it is critical to develop novel treatments and animal
models for these symptoms. One commonly used rat model is utilizing operant
effort-based choice behavior, which assesses the tendency of animals to select high-effort
activities when given a choice between multiple alternatives.

EFFORT BASED CHOICE TASKS
Motivation can be measured by various operant choice tasks, such as a T-maze
procedure developed by Salamone et al. (1994), an effort-discounting procedure
developed by Bardgett et al. (2009), and a concurrent lever-pressing/chow procedure
developed by Salamone et al. (1991). With the concurrent lever-pressing/chow procedure
used in this study, rats are placed into operant boxes and given the option to press a lever
in order to obtain small but preferred pellets (high effort/high reward) or to eat given
and standard lab chow (low effort/low reward). Thus, the amount of times the lever was
pressed in contrast to the amount of lab chow eaten can be considered a suitable
measure for the motivation of the rats. The operant box can be put onto multiple
schedules, including: an FR1 schedule in which every time the lever is pressed the rat is
given a pellet, which is typically used for pre-experimental training; an FR5 schedule in
which every five times the lever is pressed the rat is given a pellet; and a progressive
ratio (PROG) schedule, which gradually increases the ratio lever pressing requirement
over the course of the session. The baseline behavior pattern for most rats on the
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FR5/chow feeding choice task is to have high amounts of lever pressing and low amounts
of chow consumption, whereas the baseline for most rats on the PROG/chow feeding
choice task is marked by relatively lower amounts of lever pressing and relatively higher
amounts of chow consumption, due to the PROG schedule being more difficult (Randall et
al. 2012). Because of the difference in baseline activity between FR5 scheduling and
PROG scheduling, operant boxes are programmed on the FR5/chow feeding choice task in
order to observe depressive effects from drug intervention (i.e., a drug that shifts
behavior from lever pressing to chow consumption), and they are programmed to run on
the PROG/chow feeding choice task schedule in order to more easily observe increased
selection of the high-effort PROG lever pressing activity, which is a marker of increased
exertion of effort.
After extensive research in rodent models, effort-based decision making procedures
were developed in humans. In a study conducted by Treadway et al. (2009), a task called
the Effort-Expenditure for Rewards Task (EEfRT) was developed, and it was conducted on
a variety of human subjects. Patients with major depressive disorder, along with healthy
controls, were given a task wherein they could let the subject choose between pressing a
button 100 times with a non-dominant pinky to receive a higher monetary reward
(ranging from $1.24-$4.30) or press a button 30 times with the index finger of a dominant
hand within 7 seconds to receive a lower monetary reward ($1.00). There is a striking
similarity between this task and that of the rat pressing a lever for a higher reward. The
EEfRT task has also illustrated a correlation of individual differences in willingness to
exert greater effort for further rewards with dopamine transmission in the left striatum
and the ventromedial prefrontal cortex (Treadway et al. 2012). This trend of having
greater dopamine transmission in these brain areas and being more willing to choose a
higher effort/reward option has been shown to be consistent in rats as well (Randall et al.
7

2012, Salamone et al. 2016). Thus, the molecular and behavioral basis of fatigue as a
result of depression or other psychiatric illness in humans can be reliably demonstrated
and studied through rat choice procedures. The neurotransmitter dopamine is highly
involved in these procedures (Salamone et. al 2018), and thus studying the molecular
mechanisms of dopaminergic involvement in effort-related aspects of motivation is
important.

DOPAMINE
Although the dopamine system is often seen as a “reward system,” this view is largely
oversimplified; dopamine is responsible for a much wider variety of psychological
processes such as effort exertion, decision making, reinforcement learning, and habit
formation (Salamone & Correa 2012). The mesolimbic dopamine system in the brain is
the key neural circuitry in mediating motivational processes (Salamone et al. 2016,
Nunes et al. 2013, Salamone et al. 2018). The dopamine neurons for this system originate
in the ventral tegmental area in the midbrain, and terminate within the nucleus
accumbens in the ventral striatum.
Nucleus accumbens dopamine is key for motivational processes, and dysfunctions in the
nucleus accumbens contribute to a wide variety of psychopathologies involving lack of
motivation such as major depressive disorder. Mesolimbic dopamine is crucial within
the nucleus accumbens. Dopamine transport (DAT) blockers such as methylphenidate
have been shown to heighten levels of mesolimbic dopamine within the nucleus
accumbens, such as methylphenidate and modafinil (Rotolo et. al 2020).
Anatomical studies cited in Nunes et al. (2013b) have shown that adenosine 𝐴2𝐴 receptor
8

subtypes are colocalized with dopamine transmission, with them being expressed mainly
in the nucleus accumbens and other neostriatal areas of the brain. Adenosine-dopamine
interactions take place at the signal transduction level inside accumbens neurons that
receive dopamine inputs, and thus many 𝐴2𝐴 antagonists such as MSX-3 and KW-6002
have been observed reversing the effects of fatigue (Nunes et al. 2013b). It has also been
observed that dopamine receptors in the nucleus accumbens are different in male and
female rats; according to Williams et al. 2021, adult male rats have an overproduction of
dorsal striatal D1 receptors in the nucleus accumbens in comparison to female rats.
Tetrabenazine (TBZ), an inhibitor of vesicular monoamine transporter-2 (VMAT-2), was
used in the present study to induce depressive effects. TBZ presents itself as a
reserpine-type antipsychotic and is used to treat Huntington’s, Parkinson’s, and other
movement disorders, but its main side effect is the induction of depressive symptoms
(Salamone et al. 2016, Nunes et al. 2013b). The greatest impact of TBZ is shown in the
blockage of striatal dopamine, thus reducing motivation. It was shown in a study by
Nunes et al. (2013a) that injection of 20.0 µg of TBZ directly into the nucleus accumbens
of rats significantly altered lever pressing and chow intake by decreasing the likelihood
of them choosing the high effort/high reward option and increasing the likelihood of
choosing the low effort/low reward option. This, in addition to having the comparison of
injection of TBZ to a control area next to the nucleus accumbens and having no
significant effect, shows that TBZ has effects directly in the nucleus accumbens.

TBZ REVERSAL
Depressive effects of TBZ have been reversed by certain types of antidepressants. While
9

SSRIs, such as fluoxetine or citalopram, as well as the NE transport inhibitor desipramine
have no effect on TBZ reversal (Salamone et al. 2018, Yohn et al. 2016), dopamine uptake
inhibitors have a significant effect. These include bupropion, lisdexamfetamine
(Vyvanse), modanofil, pilocarpine, and, as talked about in this study, methylphenidate
(MPH) (Salamone et al. 2018, Nunes et al. 2013b, Yohn et al. 2016). MPH, which has been
reported to increase self-reported energy and psychomotor activity within hours after
administration (Stotz et al. 1999), can be used to induce motivational effects in patients
with Parkinson’s, major depressive disorder, narcolepsy, and most commonly ADHD
(Salamone et al. 2016, Mayo Clinic 2022).
In Salamone et al. 2016, TBZ reversal was observed with MPH in a group of eight male
rats on the FR5/chow feeding choice task. A dosage of 0.75 mg/kg of TBZ was sufficient to
induce depressive effects in this group. Rats that were given solely a vehicle, or control,
dose, had high lever presses and low chow consumption (preference towards high
effort/high reward option) and rats that were given 0.75 mg/kg TBZ without MPH had
relatively much lower lever presses and higher chow consumption (preference towards
low effort/low reward option). All rats were given different doses of MPH after being
given the standard dose of TBZ on random days, and all doses (ranging from 0.5 to 4.0
mg/kg MPH) produced a significant effect compared to rats who were administered TBZ
but not MPH.
Even though TBZ reversal with MPH has been extensively studied in male rats, there has
been a lack of knowledge on how this phenomenon may be different from females. In
humans, mental disorders vary widely between males and females, such as in major
depressive disorder. Females have an earlier age-at-onset than their male counterparts,
as well as exhibit more depressive episodes, symptoms, and atypical depressive features
10

(Smith et al. 2008). While reasoning behind these differences likely has many factors,
reasons for differences between males and females are likely molecular. Studying rats as
a model for the phenomenon of these sex differences in depression is crucial. Therefore,
the present study finds a different ideal dosage of TBZ for females and examines its
reversal with MPH.

MATERIALS AND METHODS
ANIMALS
Eight adult female Sprague Dawley rats (Harlan-Sprague Dawley) were used throughout
this study. They were pair housed, and both temperature and humidity conditions were
consistently monitored. They were given 12 hour light/dark cycles where lights were
turned on at 7:00 am and turned off at 7:00 pm. Rats initially weighed between 275 and
299 grams, and were food restricted to 85% of their free feeding body weight. They were
allowed a modest weight gain, where each rat’s weight was monitored daily and nightly
lab chow feeding was administered appropriately. They were also given water constantly
and conditions and animal protocols were approved by the University of Connecticut
institutional animal care and use committee, which followed guidelines from the
National Institute of Health.

PHARMACOLOGICAL AGENTS
Tetrabenazine [(R,R)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-pyrido[2,1-a]isoquinolin-2-one] was obtained from Tocris Bioscience. It was dissolved in a 20% dimethyl
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sulfoxide (DMSO) solution, and small amounts of hydrochloric acid (HCl) were used to
bring the solution to a pH level between 4.0 and 4.5. The vehicle control used in this
study is the same DMSO and HCl solution used to dissolve the tetrabenazine.
Methylphenidate was obtained from the Cayman Chemical Company, and was dissolved
in 0.9% saline. The dosages of TBZ were initially based on previous studies in our lab
with male rats (Salamone et al. 2016) but, as is discussed later in the paper, upon
understanding that female rats need a higher dose of 2.0 mg/kg of TBZ it was found to be
effective and was thus used throughout the rest of the study.

BEHAVIORAL PROCEDURE: FR5/CHOICE
FR5/chow feeding choice task utilizing operant chambers (28 x 23 x 23 cm3; Med
Associates, Fairfax, VT) were used to conduct behavioral sessions. Eight female rats were
introduced to high carbohydrate pellets (45 mg, Bio-Serv, Frenchtown, NJ). They then
went through magazine training for two days, which consisted of one pellet being
received every thirty seconds while on an FR1 reinforcement schedule where one lever
press is always rewarded with one pellet. Rats were then put on an FR1 reinforcement
schedule without the magazine training for three days and then moved onto the FR5
schedule (five lever presses are needed to be rewarded with one pellet). Once this lever
pressing training period was completed, rats were introduced to a choice food option of
lab chow (Laboratory Diet, 5P00 Prolab RMH 3000, Purina Mills, St. Louis, MO; about
17-21 g) for five weeks. After every operant session (30 minutes), the number of lever
presses as well as the weight of the chow that was consumed (including spillage) was
recorded. Drug testing began after this training period was over. Rats were weighed
every day and given supplemental food as necessary in order to allow rats a modest
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weight gain. Most often, chow food was only given after weekly drug trials and over
weekends in order to supplement feeding.

BEHAVIORAL EXPERIMENT
Rats were trained on the FR5/chow feeding procedure, as described above, and
behavioral sessions were conducted five days per week (Monday-Friday). Drug trials
were run once per week. During the first part of the study, eight rats (n=8) were given
different doses of TBZ (either vehicle control, 0.25 mg/kg, 0.5 mg/kg, 0.75 mg/kg, or 1.0
mg/kg) in a randomized order for six weeks, so that each rat had each dose at least once.
These doses were based off of the doses in male rat studies from Salamone et. al 2016.
After no effect was observed, rats received either 2.0 mg/kg TBZ or the vehicle control for
two weeks. Because 2.0 mg/kg TBZ was found to be an effective dose for inducing
depression in female rats, this dose was used during the second portion of the study. Two
hours before behavioral procedures, rats were either given vehicle control or 2.0 mg/kg
TBZ. After 1.5 hours, rats were then given different doses of MPH (a vehicle control, 0.5
mg/kg, 1.0 mg/kg, 2.0 mg/kg, or 4.0 mg/kg). After operant procedures, lever presses were
recorded and excess chow was weighed as described above.

STATISTICAL ANALYSIS
Results were analyzed with repeated-measures analysis of variance (ANOVA) by using
SPSS version 28 (IBM, US). For the significant ANOVA results, Tukey’s pairwise
comparisons were used.
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RESULTS
Figure 1.
A

L.P. VEH vs. 2.0 mg/kg TBZ t(7) = 6.34, p < 0.001

B

Chow VEH vs. 2.0 mg/kg TBZ t(7) = -5.11, p < 0.001

Figure 1. Deciphering appropriate TBZ doses to induce depressive effects in female rats. The first
vehicle dose as well as low doses of TBZ were given in random order to a group of female rats (n=8). All low
doses did not significantly differ from the first vehicle dose with both lever pressing and chow consumption.
A second vehicle dose was then given and 2.0 mg/kg TBZ were administered via IP injection. A, Mean (±SEM)
number of lever presses (FR5/chow schedule) during the 30 minute session. B, Mean (±SEM) gram quantity of
chow intake during the 30 minute session. This dose of TBZ was found to be significantly different from the
initial dose with p < 0.001 for both lever pressing and chow consumption. Data are from Ecevitoglu et al. in
preparation).
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Figure 2.
A

L.P. VEH/VEH vs TBZ/VEH F(1,7)=29.56, p < .05
L.P. T/VEH vs T/2.0 F(1,7)=13.05, p < .05

B

Chow VEH/VEH vs TBZ/VEH F(1,7)=20.35, p < .05
Chow T/VEH vs T/2.0 F(1,7)=17.98, p < .05
Chow T/VEH vs T/2.0 F(1,7)= 32.71, p < .05

Figure 2. The effect of TBZ reversal with MPH on female rats. Female rats (n=8) were either given two
vehicle doses in succession to each other, TBZ followed by a vehicle, or TBZ followed by either 0.5 mg/kg, 1.0
mg/kg, 2.0 mg/kg, or 4.0 mg/kg MPH. These dosages were received randomly and each rat received each dose
at least once. A, Mean (±SEM) number of lever presses (FR5/chow schedule) during the 30 minute session. B,
Mean (±SEM) gram quantity of chow intake during the 30 minute session. The VEH/VEH dose was found to be
significantly different than the TBZ/VEH dose with p < 0.05 for both lever pressing and chow consumption.
The TBZ/VEH dose was found to be significantly different than the TBZ/2.0 dose with p < 0.05 for both lever
pressing and chow consumption with p < 0.05. The TBZ/VEH dose was found to be significantly different than
the TBZ/4.0 dose for only chow consumption with p < 0.05.
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The results of the first part of the experiment are shown in Figure 1. The higher dose of
TBZ in comparison to the second vehicle had a significant effect in both lever pressing
(t(7) = 6.34, p < 0.001) and chow consumption (t(7) = -5.11, p < 0.001).
The results of the second part of the experiment, in which TBZ was reversed with MPH,
was shown in Figure 2. There was a significant difference between rats who received
both vehicle doses (V/VEH) and rats who received the TBZ and the vehicle (T/VEH) both
the amount of lever presses (F(1,7)=29.56, p < .05) and the amount of chow consumption
(F(1,7)=20.35, p < .05), which indicates that the presence of TBZ has a significant effect in
decreasing lever pressing and increasing chow consumption. The dose of 2.0 mg/kg TBZ
combined with 2.0 mg/kg MPH (T/2.0 compared to T/VEH) was found to significantly
reverse the effects of lowered lever pressing (F(1,7)=13.05, p < .05) and raised chow
consumption (F(1,7)=17.98, p < .05). The dose of 2.0 mg/kg TBZ combined with 4.0 mg/kg
MPH (T/4.0 compared to T/VEH) did not significantly alter lever pressing but did
significantly alter chow consumption (F(1,7)= 32.71, p < .05).

DISCUSSION
This study focused on the depression-like motivational effects of the VMAT-2 inhibitor
TBZ in females in order to determine if those effects could be reversed by administration
of the DAT inhibitor methylphenidate. A concurrent FR5 lever pressing/chow procedure
can be used to measure motivation in rats (Salamone et al. 1991). This procedure was
used in the present study to establish the effort-related effects of TBZ in female rats, and
to determine if MPH could reverse the effects of TBZ. As discussed above, a dose of 2.0
mg/kg TBZ is necessary in female rats for producing the shift in effort-based choice,
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because female rats are less sensitive than male rats (Ecevitoglu et al. in preparation). In
the present study, the low-effort bias was observed with a dose of 2.0 mg/kg TBZ, as by
the fact that lever pressing was reduced by TBZ compared to vehicle (Figure 1), and
chow intake was increased. This greatly contrasts with previous studies of male rats. In
these studies, low-effort bias was induced by lower doses of TBZ (Nunes et al. 2013;
Salamone et al. 2016). It is not clear why female rats are less sensitive to the effects of
TBZ compared to male rats. The reasoning behind this may be due to different molecular
mechanisms of dopamine and dopamine antagonism between males and females.
According to Williams et al. (2021), adult male rats have an overproduction of dorsal
striatal D1 receptors in the nucleus accumbens in comparison to female rats. Since TBZ
has been shown to target the nucleus accumbens (Nunes et al. 2013a), TBZ having less
effect on dopamine depletion in the nucleus accumbens in females may be due to their
lack of D1 dopamine receptors in this area. Thus, a higher dose of TBZ was required to
induce effort-related motivations dysfunctions in female rats compared to male rats.
Determining this was critical for determining if MPH could reverse the effects of TBZ in
females.
It was found in Figure 2 that the DAT inhibitor MPH was able to partially but
significantly reverse the effects of TBZ, increasing lever pressing and decreasing chow
intake in TBZ-treated rats. The most effective dose for reversing the lever pressing effects
of TBZ was 2.0 mg/kg of MPH. This is the only dose at which lever pressing was found to
be significantly higher than doses 2.0 mg/kg TBZ condition. Chow consumption was also
found to be significantly lower than vehicle doses for both the 2.0 mg/kg and 4.0 mg/kg
doses of MPH. The reason why 4.0 mg/kg MPH induced significantly lower chow
consumption but statistically similar lever pressing in comparison to the vehicle dose of
MPH is that the higher dose of 4.0 mg/kg MPH induced appetite-suppressing effects. High
17

doses of MPH are known to cause appetite suppression (Davis et al. 2007).
Since MPH is able to reverse the decrease in motivation caused by TBZ, it may prove to
be a promising treatment for patients who are suffering with motivational dysfunctions.
While other antidepressants, such as SSRIs, may help with improving mood, they are
relatively ineffective in comparison to DAT inhibitors such as MPH, which may be used to
reverse motivational deficits in patients across many pathologies (Salamone et al. 2018,
Yohn et al. 2016). Further understanding of dopamine and its differences between males
and females in rats may directly translate into molecular mechanisms of dopamine in
humans, and may be vital in clinical settings (Salamone et al. 2018).
Future directions of these studies may include testing effects of TBZ on other
operant-based schedules, such as PROG rather than FR5. These experiments may also be
repeated using other DAT inhibitors to counter TBZ, such as bupropion,
lisdexamfetamine (Vyvanse), modanofil, and pilocarpine (Salamone et al. 2018, Nunes et
al. 2013b, Yohn et al. 2016). This may allow us to further our understanding of dopamine
transmission across both males and females and translate our knowledge into vital
clinical practice for human patients.
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